|
original article |
Date |
Title |
Authors All Authors |
1 |
[GO] |
2023―Nov―29 |
Antimicrobial resistance rates of urogenital Mycoplasma hominis and Ureaplasma species before and during the COVID-19 pandemic: results from a Greek survey, 2014 to 2022 |
Karolina Akinosoglou, Aristotelis Tsiakalos, Ioanna D. Dimopoulou, Georgios Schinas, Eleni Polyzou, Jenny Kourea-Kremastinou, Vassiliki C. Pitiriga |
2 |
[GO] |
2023―Nov―24 |
Evaluation of A-ring hydroxymethylene-amino- triterpenoids as inhibitors of SARS-CoV-2 spike pseudovirus and influenza H1N1 |
Oxana Kazakova, Xinyuan Ma, Elena Tretyakova, Irina Smirnova, Alexander Slita, Ekaterina Sinegubova, et al. (+4) Vladimir Zarubaev, Hongwei Jin, Demin Zhou, Sulong Xiao |
3 |
[GO] |
2023―Apr―25 |
Prophylactic administration of ivermectin attenuates SARS-CoV-2 induced disease in a Syrian Hamster Model |
Takayuki Uematsu, Tomomi Takano, Hidehito Matsui, Noritada Kobayashi, Satoshi Ōmura, Hideaki Hanaki |
4 |
[GO] |
2021―Dec―21 |
The mechanisms of action of ivermectin against SARS-CoV-2-an extensive review |
Asiya Kamber Zaidi, Puya Dehgani-Mobaraki |
5 |
[GO] |
2021―Jun―15 |
The mechanisms of action of Ivermectin against SARS-CoV-2: An evidence-based clinical review article |
Asiya Kamber Zaidi, Puya Dehgani-Mobaraki |
6 |
[GO] |
2020―Jun―12 |
Ivermectin: a systematic review from antiviral effects to COVID-19 complementary regimen |
Fatemeh Heidary, Reza Gharebaghi |